Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y
Go back to Nektar Therapeutics (NKTR) Posts Q2 EPS Loss of $0.32, Revenues 60% Y/Y| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.55 +1.31 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.24 | 52 Week High | $19.98 | |||
| Open | $59.96 | 52 Week Low | $10.52 | |||
| Day High | $62.40 | P/E | N/A | |||
| Day Low | $58.91 | EPS | $-1.45 | |||
| Volume | 1,209,945 | |||||
